Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/stem.1746 http://scihub22266oqcxt.onion/10.1002/stem.1746 C4138251!4138251!24809620     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Stem+Cells 2014 ; 32 (9): 2309-23 Nephropedia Template TP {{tp|p=24809620|t=2014. Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1 |pdf=|usr=}}{{24809620}} gab.com Text Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1 JO: Stem Cells http://www.kidney.de/pget.php?&tw=1&pmid=24809620 #FOAvip Triple negative breast cancer (TNBC) is known to contain a high percentage of CD44+/CD24?/low cancer stem cells (CSC), corresponding with a poor prognosis despite systemic chemotherapy. Chloroquine (CQ), an anti-malarial drug, is a lysotropic reagent which inhibits autophagy. CQ was identified as a potential CSC inhibitor through in silico gene expression signature analysis of the CD44+/CD24?/low CSC population. Autophagy plays a critical role in adaptation to stress conditions in cancer cells, and is related with drug resistance and CSC maintenance. Thus the objectives of this study were to examine the potential enhanced efficacy arising from addition of chloroquine (CQ) to standard chemotherapy (paclitaxel) in TNBC and to identify the mechanism by which CQ eliminates CSCs in TNBCs. Herein, we report that CQ sensitizes TNBC cells to paclitaxel through inhibition of autophagy and reduces the CD44+/CD24?/low CSC population in both preclinical and clinical settings. Also, we are the first to report a mechanism by which CQ regulates the CSCs in TNBC through inhibition of the Janus-activated kinase 2 (Jak2) - Signal transducer and activator of transcription 3 (STAT3) signaling pathway by reducing the expression of Jak2 and DNA methyltransferase 1 (DNMT1). Twit Text FOAVip Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1 ????Stem Cells http://www.kidney.de/pget.php?&tw=1&pmid=24809620 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=24809620 #FOAvip English Wikipedia <ref>{{Cite pmid|24809620}}</ref> Chloroquine eliminates cancer stem cells through deregulation of Jak2 and DNMT1 #MMPMID24809620 Choi DS; Blanco E; Kim YS; Rodriguez AA; Zhao H; Huang THM; Chen CL; Jin G; Landis MD; Burey LA; Qian W; Granados SM; Dave B; Wong HH; Ferrari M; Wong ST; Chang JC Stem Cells 2014[Sep]; 32 (9): 2309-23 PMID24809620show ga Triple negative breast cancer (TNBC) is known to contain a high percentage of CD44+/CD24?/low cancer stem cells (CSC), corresponding with a poor prognosis despite systemic chemotherapy. Chloroquine (CQ), an anti-malarial drug, is a lysotropic reagent which inhibits autophagy. CQ was identified as a potential CSC inhibitor through in silico gene expression signature analysis of the CD44+/CD24?/low CSC population. Autophagy plays a critical role in adaptation to stress conditions in cancer cells, and is related with drug resistance and CSC maintenance. Thus the objectives of this study were to examine the potential enhanced efficacy arising from addition of chloroquine (CQ) to standard chemotherapy (paclitaxel) in TNBC and to identify the mechanism by which CQ eliminates CSCs in TNBCs. Herein, we report that CQ sensitizes TNBC cells to paclitaxel through inhibition of autophagy and reduces the CD44+/CD24?/low CSC population in both preclinical and clinical settings. Also, we are the first to report a mechanism by which CQ regulates the CSCs in TNBC through inhibition of the Janus-activated kinase 2 (Jak2) - Signal transducer and activator of transcription 3 (STAT3) signaling pathway by reducing the expression of Jak2 and DNA methyltransferase 1 (DNMT1). äChloroquine eliminates cancer stem cells through deregulation of Jak2 (epmc).pdf DeepDyve Pubget Overpricing